Kenfarb & Co. Repligen Corp Transaction History
Kenfarb & Co.
- $108 Million
- Q3 2023
A detailed history of Kenfarb & Co. transactions in Repligen Corp stock. As of the latest transaction made, Kenfarb & Co. holds 700 shares of RGEN stock, worth $104,993. This represents 0.1% of its overall portfolio holdings.
Number of Shares
700
Previous 700
-0.0%
Holding current value
$104,993
Previous $99,000
12.12%
% of portfolio
0.1%
Previous 0.09%
Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
489Shares Held
54.3MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.14 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$959 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$757 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$244 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$213 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.32B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....